Dr. Eduardo Galvan

Cardiologo Intervencionista, departamento de Hemodinamia hospital de cardiología UMAE 34, Monterrey NL, Mex. #UMAE34cathlab

[Dr. Eduardo Galvan @CardioMty]

61 yo🧓, with NSTEMI, bcs of ostial DX lesion, besides chronic subexpanded stent in proximal LAD with severe 360° calcium.
Tx..
Dx => NC 3.0 POBA and DCB.
LAD => 3.5 shockwave and DCB.
What you think about DCB use in this double scenario ( 0-0-1 bif lesion NSTEMI/ISR-calcium)??

[Dr. Eduardo Galvan @CardioMty]

Missing posting here, Lets do It again, hello everybody!

[Dr. Eduardo Galvan @CardioMty]

@ignamatsant @TurinCTO_CHIP @shci_sec @PCRonline @MLCTOAcademy @GagnorAndrea @RobertoGarbo1 Excelente @ignamatsant en horabuena!!

[Neisser M @mornei2011]

CHIP LATAM #México join us in this intiative @LAzzaliniMD @rickytiago @CiticMexico @solaci_online

[Ahmed Elsherif @Dr_Elsherif1990]

I am very pleased to share our latest publication as first author on management of coronary artery perforations in the Journal of American College of Cardiology(JACC).

Stepwise, case-based review from our UK centre.

🔗 https://t.co/gqxX7DSjIW

#JACC #cardiology #intervention

[Ignacio J. Amat @ignamatsant]

Mitral implantation of the Sapien M3 valve at HCU Valladolid.

One team, one direction: The patient.
Thank you to everyone who makes these milestones possible. Worth every sacrifice.

@sacyl @EdwardsLifesci @secardiologia @mariogago13 @AnestesiaHCUV

[Dr. Eduardo Galvan @CardioMty]

Hanging around on CRF CTO plus 2026 with friends.
@rickytiago @MauroEchavPinto @elpikos @mornei2011 Ulises Lopez, Francisco Díaz y Víctor Romero de BSCI

[Dr. Eduardo Galvan @CardioMty]

@mornei2011 @crfheart @ShariqShamimMD @evandrofilhobr @MPAOSS @OjedaOjeda18 @jedicath @LAzzaliniMD @rickytiago @mirvatalasnag @mmamas1973 @Laserrman @RumoJose @realarainmd Great result! See you there.. 😎

[Dr. Eduardo Galvan @CardioMty]

@LAzzaliniMD @UWMedHeart @KateKearney4 @DrBillLombardi @RhianEDavies1 @wjn_md @AshishPershad @JAG24851 By extending the way we treat chronic total occlusions, thinking outside the box can facilitate success #umae34cathlab #CHIPLIFE

[Lorenzo Azzalini @LAzzaliniMD]

🗞️ Hot off the press: #STAR trial
First randomized controlled trial comparing two different technical strategies in #CTO #PCI
https://t.co/ufJNmNbO2e

[European Society of Cardiology Journals @ESC_Journals]

TAVI or TAVR? A timely #EHJVSHD viewpoint reviews the historical origins, guideline evolution, and semantic accuracy of transcatheter aortic valve therapy, arguing why TAVI best reflects the procedure performed👉🔗https://t.co/8qLhjzfzB1

@EHJVSHDEiC @PanichellaG @IndolfiCiro @ESC_President @EAPCIPresident

[JAMA @JAMA_current]

.@WHO published a guideline in JAMA on the use and indications of #GLP-1 therapies for the management of #obesity in adults. The guideline offers two conditional recommendations to inform clinical practice and health policy.

Read the guideline: https://t.co/VpdzdmHPPK

[NEJM @NEJM]

Guidelines recommend dual antiplatelet therapy after CABG for acute coronary syndrome, but whether it reduces adverse events as compared with aspirin alone is unclear. Research findings from the TACSI trial are summarized in a new Quick Take video. https://t.co/zaEOWkOA5d

[EHJ Editor-in-Chief @ehj_ed]

A must-read paper in #EHJ!
Coronary revascularization: a long-term perspective.
A State-of-the-Art review forecasting advancements by 2040, drawing on historical trends and recent breakthroughs.
@escardio @ESC_Journals #CardioTwitter

https://t.co/2I8oeozR6s

[Dr. Eduardo Galvan @CardioMty]

@ignamatsant Felicidades Ignacio Bien merecido 👌🏻

[Susana Farias @susyfariasv]

ACTUALIZACIÓN: CONTRADICCIONES ENTRE PLANTA Y CONCESIONARIO
Adquirí una Volkswagen Tiguan 2025 R-Line el 23 de julio 2025. Confié en la marca y en su seguridad. Hoy, después de 3 ingresos a garantía y casi 3 meses sin mi vehículo, sigo sin solución. @Volkswagen_MX @Profeco

[Gregg W. Stone MD @GreggWStone]

Provocative study from the RENOVATE trialists and Samsung Med Cntr suggesting use of intravascular imaging may eliminate long-term diffs between CABG & PCI. Not definitive absent a powered RCT, but should be enough to mandate IVI in these pts, esp with class I guidelines. Agree?

[REC Publications @RevEspCardiol]

Estrategia de reducción de stents frente a revascularización coronaria percutánea convencional en el IAMCEST: diseño del ensayo COPERNICAN #REC #Aheadofprint @sjorge4 @drassantos @EvaRumiz @AntonioGomezM21 @fer_iver @cardioyoguini @hect2701 @ignamatsant https://t.co/qhxdaAzUow

[EuroIntervention @EuroInterventio]

📢 NEW State-of-the-Art Review
Advanced coronary imaging techniques—IVUS, OCT, NIRS, and CCTA—enable detailed assessment of plaque morphology, vulnerability, and therapeutic response.
This comprehensive review by García-García et al. outlines current evidence and clinical implications.
Read here: https://t.co/nGKsQAZrIt

@hect2701 @sjorge4 @christosbouran1
#Cardiology #Atherosclerosis #CoronaryImaging

[Dr. Eduardo Galvan @CardioMty]

Knowledge, dinner, and friends, great night with @mmamas1973 an friends in #CITIC Mexico City. Hope you had have a safe come back home @mmamas1973

[Dr. Eduardo Galvan @CardioMty]

@KambisMashayek1 @CtoEuro Oohh god 😭, rest in peace great interventionalist, leaves behind great legacy, condolences to his family.